Evaluation of Optical Genome Mapping in Phi Negative Myeloproliferative Neoplasia in the Detection of Acquired Cytogenetic Abnormalities

NCT05714592 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Myeloproliferative Neoplasm
Optical Genome Mapping
Cytogenetics
Clonality
Prognostic Stratification

Interventions

OTHER: Blood sample

Sponsor

Centre Hospitalier Universitaire, Amiens

Collaborators

[object Object]
[object Object]